Search Results 'Bone therapeutics'

Bone Therapeutics raises EUR 32.2 million through IPO

Bone Therapeutics raises EUR 32.2 million through IPO

Bone Therapeutics – a Walloon cell therapy company specialized in bone fracture repair and prevention – shifts up a gear and raises EUR 32.2 million in a 2.5x oversubscribed successful IPO on Brussels and Paris Euronext [...]

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant1 in the amount of €3.8 million. The grant will fund a four-year project entitled BIO-INSPIRE [...]

New developments further strengthen Bone Therapeutics’ cell product manufacturing capabilities

New developments further strengthen Bone Therapeutics’ cell product manufacturing capabilities

Updating on the February 15th post, some exciting new developments have recently occurred that further strengthen Bone Therapeutics’ cell product manufacturing capabilities. Following a successful Series D fundraising round, Bone Therapeutics, alongside the Walloon Region and private [...]

Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials

Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials

Following the approval of the pivotal phase III osteonecrosis trial of PREOB® last November (posted Nov. 9, 2012), Bone Therapeutics has just completed a €7.7 million Series D fundraising round. Of the raised funds, €6.1 million were [...]

Bone Therapeutics gets approval for pivotal phase III osteonecrosis trial in Europe and treats first patients with their Advanced Therapy Medicinal Product PREOB®

Bone Therapeutics gets approval for pivotal phase III osteonecrosis trial in Europe and treats first patients with their Advanced Therapy Medicinal Product PREOB®

After receiving clearance from the competent authorities in Europe for its phase III pivotal osteonecrosis* trial with their second generation Advanced Therapy Medicinal Product (ATMP), PREOB®, bone regenerative medicine company Bone Therapeutics recently announced that their [...]

Euroscreen(Gosselies,Belgium): selling “Euroscreen FAST” to focus on state-of-the-art small molecule drug therapeutics

Euroscreen(Gosselies,Belgium): selling “Euroscreen FAST” to focus on state-of-the-art small molecule drug therapeutics

Euroscreen, a spin-off of ULB with plans of establishing a treatment for endometriosis*, is putting its “services business unit” up for sale. Recognizing the need for capital increases like the other active companies in the biotechnologies [...]

Walloon Biotech and Medtech companies: should you go for an IPO?

Walloon Biotech and Medtech companies: should you go for an IPO?

Initial Public Offerings tend to become a real alternative for more and more European biotech companies. In Wallonia (Belgium), several SMEs (such as Mithra Pharmaceuticals) are seriously considering this option while companies such as Celyad, Bone [...]

Pluriomics raises €4M and settles its production facility in Wallonia!

Pluriomics raises €4M and settles its production facility in Wallonia!

Pluriomics, an emerging biotech company located in Leiden (The Netherlands) and specializing in the delivery of innovative cardiomyocyte models, has raised €4 million in a Series A round to strengthen its R&D and commercial team in [...]

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

The first European Advanced Therapies Investor Day began with the sound of  the “opening bell” of the Euronext stock market (Brussels) resonating the potential of the rapidly expanding sector of advanced therapies. Watch ceremony For the [...]

Public-private partnership leads to unique Walloon Cell Therapy Platform

Public-private partnership leads to unique Walloon Cell Therapy Platform

As the foundation for the new Walloon Cell Therapy Platform* begins to set in Gosselies, Belgium an exciting new development for Wallonia gets underway. The platform, unique in this sector, will provide Wallonia with a new [...]